These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 17056340

  • 1. Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure.
    Araújo JP, Azevedo A, Lourenço P, Rocha-Gonçalves F, Ferreira A, Bettencourt P.
    Am J Cardiol; 2006 Nov 01; 98(9):1248-50. PubMed ID: 17056340
    [Abstract] [Full Text] [Related]

  • 2. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M.
    Crit Care Med; 2006 Aug 01; 34(8):2140-4. PubMed ID: 16763507
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA, Fink J, Nass C, Chen H, Christenson R, deFilippi CR.
    Am J Cardiol; 2006 May 15; 97(10):1530-4. PubMed ID: 16679099
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R, Fellner B, Haoula D, Jordanova N, Heinz G, Karth GD, Huber K, Geppert A.
    Crit Care Med; 2009 Jun 15; 37(6):1837-44. PubMed ID: 19384228
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure.
    van Kimmenade RR, Pinto YM, Bayes-Genis A, Lainchbury JG, Richards AM, Januzzi JL.
    Am J Cardiol; 2006 Aug 01; 98(3):386-90. PubMed ID: 16860029
    [Abstract] [Full Text] [Related]

  • 9. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
    Schou M, Gustafsson F, Kistorp CN, Corell P, Kjaer A, Hildebrandt PR.
    Am J Cardiol; 2007 Nov 15; 100(10):1571-6. PubMed ID: 17996522
    [Abstract] [Full Text] [Related]

  • 10. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.
    J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981
    [Abstract] [Full Text] [Related]

  • 11. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ, Zareba W, Bisognano JD.
    Am J Cardiol; 2007 Apr 15; 99(8):1143-5. PubMed ID: 17437744
    [Abstract] [Full Text] [Related]

  • 12. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
    Kotanidou A, Karsaliakos P, Tzanela M, Mavrou I, Kopterides P, Papadomichelakis E, Theodorakopoulou M, Botoula E, Tsangaris I, Lignos M, Ikonomidis I, Ilias I, Armaganidis A, Orfanos SE, Dimopoulou I.
    Shock; 2009 Apr 15; 31(4):342-7. PubMed ID: 18791494
    [Abstract] [Full Text] [Related]

  • 13. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
    Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G.
    Crit Care Med; 2007 Oct 15; 35(10):2268-73. PubMed ID: 17717488
    [Abstract] [Full Text] [Related]

  • 14. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    J Heart Lung Transplant; 2007 May 15; 26(5):516-21. PubMed ID: 17449423
    [Abstract] [Full Text] [Related]

  • 15. No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure.
    Nilsson BB, Westheim A, Risberg MA, Arnesen H, Seljeflot I.
    Scand Cardiovasc J; 2010 Aug 15; 44(4):223-9. PubMed ID: 20636229
    [Abstract] [Full Text] [Related]

  • 16. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG, Hua W, Zhang S, Chu JM, Chen KP, Wang Y, Wang FZ, Chen X.
    Chin Med J (Engl); 2009 Mar 20; 122(6):617-21. PubMed ID: 19323922
    [Abstract] [Full Text] [Related]

  • 17. Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: a report from the BELSTRESS study.
    De Sutter J, De Bacquer D, Cuypers S, Delanghe J, De Buyzere M, Kornitzer M, De Backer G.
    Eur Heart J; 2005 Dec 20; 26(24):2644-9. PubMed ID: 16204267
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
    Lam CS, Burnett JC, Costello-Boerrigter L, Rodeheffer RJ, Redfield MM.
    J Am Coll Cardiol; 2007 Mar 20; 49(11):1193-202. PubMed ID: 17367664
    [Abstract] [Full Text] [Related]

  • 20. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.